144 related articles for article (PubMed ID: 38855392)
1. Clinical Outcome Assessments and Digital Health Technologies Supporting Clinical Trial Endpoints in Early Parkinson's Disease: Roundtable Proceedings and Roadmap for Research.
O'Hanlon CE; Farmer CM; Ryan J; Ernecoff N
Rand Health Q; 2024 Jun; 11(3):1. PubMed ID: 38855392
[TBL] [Abstract][Full Text] [Related]
2. A Proposed Roadmap for Parkinson's Disease Proof of Concept Clinical Trials Investigating Compounds Targeting Alpha-Synuclein.
Merchant KM; Cedarbaum JM; Brundin P; Dave KD; Eberling J; Espay AJ; Hutten SJ; Javidnia M; Luthman J; Maetzler W; Menalled L; Reimer AN; Stoessl AJ; Weiner DM;
J Parkinsons Dis; 2019; 9(1):31-61. PubMed ID: 30400107
[TBL] [Abstract][Full Text] [Related]
3. The Michael J. Fox Foundation for Parkinson's Research Strategy to Advance Therapeutic Development of PINK1 and Parkin.
Padmanabhan S; Polinski NK; Menalled LB; Baptista MAS; Fiske BK
Biomolecules; 2019 Jul; 9(8):. PubMed ID: 31344817
[TBL] [Abstract][Full Text] [Related]
4. The value of co-creating a clinical outcome assessment strategy for clinical trial research: process and lessons learnt.
Morel T; Schroeder K; Cleanthous S; Andrejack J; Blavat G; Brooks W; Gosden L; Siu C; Ratcliffe N; Slagle AF
Res Involv Engagem; 2023 Oct; 9(1):98. PubMed ID: 37876009
[TBL] [Abstract][Full Text] [Related]
5. Digital endpoints in clinical trials of Alzheimer's disease and other neurodegenerative diseases: challenges and opportunities.
Brem AK; Kuruppu S; de Boer C; Muurling M; Diaz-Ponce A; Gove D; Curcic J; Pilotto A; Ng WF; Cummins N; Malzbender K; Nies VJM; Erdemli G; Graeber J; Narayan VA; Rochester L; Maetzler W; Aarsland D
Front Neurol; 2023; 14():1210974. PubMed ID: 37435159
[TBL] [Abstract][Full Text] [Related]
6. Exercise- and strategy-based physiotherapy-delivered intervention for preventing repeat falls in people with Parkinson's: the PDSAFE RCT.
Ashburn A; Pickering R; McIntosh E; Hulbert S; Rochester L; Roberts HC; Nieuwboer A; Kunkel D; Goodwin VA; Lamb SE; Ballinger C; Seymour KC
Health Technol Assess; 2019 Jul; 23(36):1-150. PubMed ID: 31339100
[TBL] [Abstract][Full Text] [Related]
7. A Call to Action: Promoting Diversity, Equity, and Inclusion in Parkinson's Research and Care.
Siddiqi B; Koemeter-Cox A
J Parkinsons Dis; 2021; 11(3):905-908. PubMed ID: 33843698
[TBL] [Abstract][Full Text] [Related]
8. Assessment of heterogeneity among participants in the Parkinson's Progression Markers Initiative cohort using α-synuclein seed amplification: a cross-sectional study.
Siderowf A; Concha-Marambio L; Lafontant DE; Farris CM; Ma Y; Urenia PA; Nguyen H; Alcalay RN; Chahine LM; Foroud T; Galasko D; Kieburtz K; Merchant K; Mollenhauer B; Poston KL; Seibyl J; Simuni T; Tanner CM; Weintraub D; Videnovic A; Choi SH; Kurth R; Caspell-Garcia C; Coffey CS; Frasier M; Oliveira LMA; Hutten SJ; Sherer T; Marek K; Soto C;
Lancet Neurol; 2023 May; 22(5):407-417. PubMed ID: 37059509
[TBL] [Abstract][Full Text] [Related]
9. Comparative pharmacovigilance assessment of mortality with pimavanserin in Parkinson disease-related psychosis.
Brown JD; Cicali B; Henriksen C; Malaty I; Okun MS; Armstrong MJ
J Manag Care Spec Pharm; 2021 Jun; 27(6):785-790. PubMed ID: 34057395
[No Abstract] [Full Text] [Related]
10. Large-scale identification of clinical and genetic predictors of motor progression in patients with newly diagnosed Parkinson's disease: a longitudinal cohort study and validation.
Latourelle JC; Beste MT; Hadzi TC; Miller RE; Oppenheim JN; Valko MP; Wuest DM; Church BW; Khalil IG; Hayete B; Venuto CS
Lancet Neurol; 2017 Nov; 16(11):908-916. PubMed ID: 28958801
[TBL] [Abstract][Full Text] [Related]
11. Patient Experience in Early-Stage Parkinson's Disease: Using a Mixed Methods Analysis to Identify Which Concepts Are Cardinal for Clinical Trial Outcome Assessment.
Morel T; Cleanthous S; Andrejack J; Barker RA; Blavat G; Brooks W; Burns P; Cano S; Gallagher C; Gosden L; Siu C; Slagle AF; Trenam K; Boroojerdi B; Ratcliffe N; Schroeder K
Neurol Ther; 2022 Sep; 11(3):1319-1340. PubMed ID: 35778541
[TBL] [Abstract][Full Text] [Related]
12. Precompetitive Data Sharing as a Catalyst to Address Unmet Needs in Parkinson's Disease.
Stephenson D; Hu MT; Romero K; Breen K; Burn D; Ben-Shlomo Y; Bhattaram A; Isaac M; Venuto C; Kubota K; Little MA; Friend S; Lovestone S; Morris HR; Grosset D; Sutherland M; Gallacher J; Williams-Gray C; Bain LJ; Avilés E; Marek K; Toga AW; Stark Y; Forrest Gordon M; Ford S
J Parkinsons Dis; 2015; 5(3):581-94. PubMed ID: 26406139
[TBL] [Abstract][Full Text] [Related]
13. A roadmap for implementation of patient-centered digital outcome measures in Parkinson's disease obtained using mobile health technologies.
Espay AJ; Hausdorff JM; Sánchez-Ferro Á; Klucken J; Merola A; Bonato P; Paul SS; Horak FB; Vizcarra JA; Mestre TA; Reilmann R; Nieuwboer A; Dorsey ER; Rochester L; Bloem BR; Maetzler W;
Mov Disord; 2019 May; 34(5):657-663. PubMed ID: 30901495
[TBL] [Abstract][Full Text] [Related]
14. Enabling breakthroughs in Parkinson's disease with wearable technologies and big data analytics.
Cohen S; Bataille LR; Martig AK
Mhealth; 2016; 2():20. PubMed ID: 28293596
[TBL] [Abstract][Full Text] [Related]
15. Increasing Efficiency of Recruitment in Early Parkinson's Disease Trials: A Case Study Examination of the STEADY-PD III Trial.
Berk S; Greco BL; Biglan K; Kopil CM; Holloway RG; Meunier C; Simuni T
J Parkinsons Dis; 2017; 7(4):685-693. PubMed ID: 29103052
[TBL] [Abstract][Full Text] [Related]
16. RAB32 Ser71Arg in autosomal dominant Parkinson's disease: linkage, association, and functional analyses.
Gustavsson EK; Follett J; Trinh J; Barodia SK; Real R; Liu Z; Grant-Peters M; Fox JD; Appel-Cresswell S; Stoessl AJ; Rajput A; Rajput AH; Auer R; Tilney R; Sturm M; Haack TB; Lesage S; Tesson C; Brice A; Vilariño-Güell C; Ryten M; Goldberg MS; West AB; Hu MT; Morris HR; Sharma M; Gan-Or Z; Samanci B; Lis P; Periñan MT; Amouri R; Ben Sassi S; Hentati F; ; Tonelli F; Alessi DR; Farrer MJ
Lancet Neurol; 2024 Jun; 23(6):603-614. PubMed ID: 38614108
[TBL] [Abstract][Full Text] [Related]
17. Summary of NIH Medical-Surgical Emergency Research Roundtable held on April 30 to May 1, 2009.
Kaji AH; Lewis RJ; Beavers-May T; Berg R; Bulger E; Cairns C; Callaway C; Camargo CA; Carcillo J; DeBiasi R; Diaz T; Ducharme F; Glickman S; Heilpern K; Hickey R; Hoek TV; Hollander J; Janson S; Jurkovich G; Kellermann A; Kingsmore S; Kline J; Kuppermann N; Lowe R; McLario D; Nathanson L; Nichol G; Peitzman A; Richardson L; Sanders A; Shah M; Shapiro N; Silverman R; Than M; Wilber S; Yealy DM;
Ann Emerg Med; 2010 Nov; 56(5):522-37. PubMed ID: 21036293
[TBL] [Abstract][Full Text] [Related]
18. Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study.
Healy DG; Falchi M; O'Sullivan SS; Bonifati V; Durr A; Bressman S; Brice A; Aasly J; Zabetian CP; Goldwurm S; Ferreira JJ; Tolosa E; Kay DM; Klein C; Williams DR; Marras C; Lang AE; Wszolek ZK; Berciano J; Schapira AH; Lynch T; Bhatia KP; Gasser T; Lees AJ; Wood NW;
Lancet Neurol; 2008 Jul; 7(7):583-90. PubMed ID: 18539534
[TBL] [Abstract][Full Text] [Related]
19. Challenges and opportunities for improving the landscape for Lewy body dementia clinical trials.
Goldman JG; Forsberg LK; Boeve BF; Armstrong MJ; Irwin DJ; Ferman TJ; Galasko D; Galvin JE; Kaufer D; Leverenz J; Lippa CF; Marder K; Abler V; Biglan K; Irizarry M; Keller B; Munsie L; Nakagawa M; Taylor A; Graham T
Alzheimers Res Ther; 2020 Oct; 12(1):137. PubMed ID: 33121510
[TBL] [Abstract][Full Text] [Related]
20. Innovative Approaches for Slowing Disease Progression in Parkinson's Disease: Takeaways from the 14th Annual International Society for Central Nervous System Clinical Trials and Methodology Scientific Meeting.
Javidnia M; Frasier M; Shoulson I; Turkoz I; Budur K
Innov Clin Neurosci; 2020 Jan; 17(1-3):14-19. PubMed ID: 32547841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
